The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Cell Signaling by Receptor Tyrosine Kinases

Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929

AKT/PKB signaling: navigating downstream

Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115

mTOR: from growth signal integration to cancer, diabetes and ageing

Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103

MAP kinase signalling pathways in cancer

Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995

Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL

Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,578

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,244

Phosphatidylinositol-3-OH kinase direct target of Ras

Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954

Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms

Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,908

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460

Natural Modulators of Key Signaling Pathways in Skin Inflammageing

Ren, Q., Qu, L., Yuan, Y., & Wang, F. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s502252 · Cited by 29

Reversal of radiocontrast medium toxicity in human renal proximal tubular cells by white grape juice extract

Andreucci, M., Faga, T., Pisani, A., Sabbatini, M., Russo, D., Mattivi, F., Sarro, G. D., Navarra, M., & Michael, A. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.12.035 · Cited by 26

Lectin from Dioclea violacea induces autophagy in U87 glioma cells

Nascimento, A. P. M., Wolin, I. A. V., Welter, P. G., Heinrich, I. A., Zanotto‐Filho, A., Osterne, V. J. S., Lóssio, C. F., Silva, M. T. L., Nascimento, K. S., Cavada, B. S., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.04.203 · Cited by 26

Single-cell quantification of the concentrations and dissociation constants of endogenous proteins

Komatsubara, A. T., Goto, Y., Kondo, Y., Matsuda, M., & Aoki, K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007685 · Cited by 24

YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells

Bjeije, H., Soltani, B. M., Behmanesh, M., & Zali, M. R. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz146 · Cited by 26

Melanoma Metabolism: Cell Survival and Resistance to Therapy

Luís, R., Brito, C., & Pojo, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_11 · Cited by 26

Attenuation of allergen-mediated mast cell activation by rosemary extract (Rosmarinus officinalisL.)

Yousef, M., Crozier, R. W. E., Hicks, N. J., Watson, C. J. F., Boyd, T., Tsiani, E., & MacNeil, A. J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0320-434r · Cited by 26

NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity

Haider, N., Dutt, P., van de Kooij, B., Ho, J., Palomero, L., Pujana, M. Á., Yaffe, M. B., & Stambolic, V. (2020) · Oncogene · doi:10.1038/s41388-020-1361-x · Cited by 26

Targeted Therapies for the Neurofibromatoses

Sanchez, L. D., Bui, A., & Klesse, L. J. (2021) · Cancers · doi:10.3390/cancers13236032 · Cited by 26

Dabrafenib

Kainthla, R., Kim, K. B., & Falchook, G. S. (2014) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-54490-3_14 · Cited by 27

Nutrient-Mediated Perception and Signalling in Human Metabolism: A Perspective of Nutrigenomics

Lal, M. K., Sharma, E., Tiwari, R. K., Devi, R., Mishra, U. N., Thakur, R., Gupta, R., Dey, A., Lal, P., Kumar, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911305 · Cited by 30

Alpha-linolenic acid modulates systemic and adipose tissue-specific insulin sensitivity, inflammation, and the endocannabinoid system in dairy cows

Kra, G., Daddam, J. R., Moallem, U., Kamer, H., Mualem, B., Levin, Y., Kočvarová, R., Nemirovski, A., Contreras, A. G., Tam, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-32433-7 · Cited by 26

Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer

Lee, C. L., Cremona, M., Farrelly, A. M., Workman, J. A., Kennedy, S., Aslam, R., Carr, A., Madden, S. F., O’Neill, B., Hennessy, B. T., et al. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2223388 · Cited by 27

Dabrafenib for treatment of BRAF-mutant melanoma

Falchook, G. S., Kainthla, R., & Kim, K. (2013) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s37220 · Cited by 28

Secreted phospholipase A2-IIA-induced a phenotype of activated microglia in BV-2 cells requires epidermal growth factor receptor transactivation and proHB-EGF shedding

Martín, R., Córdova, C., & Nieto, M. L. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-154 · Cited by 27

Coumestrol suppresses proliferation of ES2 human epithelial ovarian cancer cells

Lim, W., Jeong, W., & Song, G. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0418 · Cited by 26

Dysembryoplastic neuroepithelial tumour: insight into the pathology and pathogenesis

Sontowska, I., Matyja, E., Malejczyk, J., & Grajkowska, W. (2017) · Folia Neuropathologica · doi:10.5114/fn.2017.66708 · Cited by 26

Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK/Akt/mTOR pathway and EGFR/FAAD proteins

jo, R. D. A. ⁄., Pessoa, J. B., Cruz, L. J., Chan, A. B., Miguel, E. D. C., Cavalcante, R. ⁄. M., Brito, G. A. D. C., Silva, H. F., Gasparotto, L. H. S., Guedes, P. M. D. M., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4179 · Cited by 26

Epigallocatechin-3-gallate confers protection against corticosterone-induced neuron injuries via restoring extracellular signal-regulated kinase 1/2 and phosphatidylinositol-3 kinase/protein kinase B signaling pathways

Zhao, X., Li, R., Jin, H., Jin, H., Wang, Y., Zhang, W., Wang, H., & Chen, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192083 · Cited by 28

Mechanical Forces and Their Effect on the Ribosome and Protein Translation Machinery

Simpson, L. J., Tzima, E., & Reader, J. S. (2020) · Cells · doi:10.3390/cells9030650 · Cited by 25

Dual‐specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem‐like cell phenotype in human endometrial cancer

Kato, M., Onoyama, I., Yoshida, S., Cui, L., Kawamura, K., Kodama, K., Hori, E., Matsumura, Y., Yagi, H., Asanoma, K., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32965 · Cited by 26

The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma

Todeschini, L., Cristin, L., Martinino, A., Mattia, A., Agnes, S., & Giovinazzo, F. (2023) · Current Oncology · doi:10.3390/curroncol30060421 · Cited by 27

Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia

Scupoli, M. T., & Pizzolo, G. (2012) · Expert Review of Hematology · doi:10.1586/ehm.12.21 · Cited by 25

Autophagy suppression sensitizes glioma cells to IMP dehydrogenase inhibition-induced apoptotic death

Isakovic, A. M., Dulović, M., Marković, I., Kravic‐Stevovic, T., Bumbasirevic, V. Z., Trajković, V., & Isaković, A. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.001 · Cited by 25

Challenges of targeting BRAF V600E mutations in adult primary brain tumor patients: a report of two cases

Smith-Cohn, M., Davidson, C. J., Colman, H., & Cohen, A. L. (2019) · CNS Oncology · doi:10.2217/cns-2019-0018 · Cited by 25

FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells.

Lee, M.-H., Yanagawa, J., Tran, L. M., Walser, T. C., Bisht, B., Fung, E., Park, S. J., Zeng, G., Krysan, K., Wallace, W. D., et al. (2020) · PubMed Central · Cited by 25

Potential role of mTORC1 and the PI3K-Akt pathway in anti-acne properties of licorice flavonoids

Ruan, S.-F., Xiang, S., Wu, W., Cao, S., Du, Q., Wang, Z., Chen, T., Shen, Q., Liu, L., Chen, H., et al. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103968 · Cited by 25

Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology

Gümüşay, Ö., Vitiello, P. P., Wabl, C. A., Corcoran, R. B., Bardelli, A., & Rugo, H. S. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280845 · Cited by 29

Ovarian transcriptomic analysis and follicular development of Leizhou black duck

Zou, K., Asiamah, C. A., Lü, L., Liu, Y., Pan, Y., Chen, T., Zhao, Z., & Su, Y. (2020) · Poultry Science · doi:10.1016/j.psj.2020.08.008 · Cited by 25

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Regulates Neurite Outgrowth Through the Activation of Akt/mTOR and Erk/mTOR Signaling Pathways

Wen, W., Wang, Y., Li, H., Xu, H., Xu, M., Frank, J. A., Ma, M., & Luo, J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.560020 · Cited by 25

A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance

Al‐Akhrass, H., Conway, J. R. W., Poulsen, A. S. A., Paatero, I., Kaivola, J., Padzik, A., Andersen, O. M., & Ivaska, J. (2021) · Oncogene · doi:10.1038/s41388-020-01604-5 · Cited by 25

The glucocorticoid receptor associates with RAS complexes to inhibit cell proliferation and tumor growth

Caratti, B., Fidan, M., Caratti, G., Breitenecker, K., Engler, M., Kazemitash, N., Traut, R., Wittig, R., Casanova, E., Ahmadian, M. R., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abm4452 · Cited by 26

Signaling pathway(s) of TNFR2 required for the immunoregulatory effect of CD4+Foxp3+ regulatory T cells

He, T., Zhao, Y., Zhao, P., Zhao, L., Zakaria, J., & Wang, K. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108823 · Cited by 25

PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer

Wang, X., Yu, J., Liu, X., Luo, D., Li, Y., Song, L., Jiang, X. L., Yin, X., Wang, Y., Chai, L., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100741 · Cited by 25

Proteome diversification by mRNA translation in cancer

Kochavi, A., Lovecchio, D., Faller, W. J., & Agami, R. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.11.014 · Cited by 24

RAS‐targeted cancer therapy: Advances in drugging specific mutations

Liu, C., Ye, D., Yang, H., Chen, X., Su, Z., Li, X., Ding, M., & Liu, Y. (2023) · MedComm · doi:10.1002/mco2.285 · Cited by 25

mTOR Inhibition Induces Compensatory, Therapeutically Targetable MEK Activation in Renal Cell Carcinoma

Bailey, S. T., Zhou, B. R., Damrauer, J. S., Krishnan, B., Wilson, H. L., Smith, A. M., Li, M., Yeh, J. J., & Kim, W. Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104413 · Cited by 26

Concomitant activation of the PI3K/Akt and ERK1/2 signalling is involved in cyclic compressive force‐induced IL‐6 secretion in MLO‐Y4 cells

Yin, J., Hao, Z., Ma, Y., Liao, S., Li, X., Fu, J., Wu, Y., Shen, J., Ping, Z., Li, X., et al. (2013) · Cell Biology International · doi:10.1002/cbin.10235 · Cited by 25

eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants

Chen, K., Yang, J., Li, J., Wang, X., Chen, Y., Huang, S., & Chen, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7164 · Cited by 26

Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice

Kwegyir‐Afful, A. K., Murigi, F. N., Purushottamachar, P., Ramamurthy, V. P., Martin, M. S., & Njar, V. C. O. (2016) · Oncotarget · doi:10.18632/oncotarget.14154 · Cited by 25

Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications

Fourneaux, B., Chaire, V., Lucchesi, C., Karanian, M., Pineau, R., Laroche‐Clary, A., & Italiano, A. (2016) · Oncotarget · doi:10.18632/oncotarget.13987 · Cited by 25

Everolimus Inhibits Growth of Gemcitabine-Resistant Pancreatic Cancer Cells via Induction of Caspase-Dependent Apoptosis and G2/M Arrest

Peng, T., & Dou, Q. P. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25921 · Cited by 25

Whole-transcriptome response to wastewater treatment plant and stormwater effluents in the Asian clam, Corbicula fluminea

Bertucci, A., Pierron, F., Gourvès, P.-Y., Klopp, C., Lagarde, G., Pereto, C., Dufour, V., Gonzalez, P., Coynel, A., Budzinski, H., et al. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.08.090 · Cited by 25

Dendritic Cells Potently Purge Latent HIV-1 Beyond TCR-Stimulation, Activating the PI3K-Akt-mTOR Pathway

van Montfort, T., van der Sluis, R. M., Darcis, G., Beaty, D. E., Groen, K., Pasternak, A. O., Pollakis, G. P., Vink, M. A., Westerhout, E. M., Hamdi, M., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.014 · Cited by 25

Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers

Mattox, T. E., Chen, X., Maxuitenko, Y. Y., Keeton, A. B., & Piazza, G. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010141 · Cited by 25

GSTP1-mediated S-glutathionylation of Pik3r1 is a redox hub that inhibits osteoclastogenesis through regulating autophagic flux

Ji, X., Hong, J., Yang, W., Yao, M., Wang, J., Jiang, G., Wang, Y., Li, C., Lin, J., Mou, H., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102635 · Cited by 25

The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling

Gordiienko, I. M., Shlapatska, L. M., Kholodniuk, V., Sklyarenko, L. M., Df, G., Clark, E. A., & Sidorenko, S. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185940 · Cited by 26

SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC

Ruiz, C. F., Montal, E. D., Haley, J. D., Bott, A. J., & Haley, J. D. (2020) · The FASEB Journal · doi:10.1096/fj.202000052r · Cited by 29

In silico authentication of amygdalin as a potent anticancer compound in the bitter kernels of family Rosaceae

Ayaz, Z., Bibi, Z., Khan, S. A., Abbasi, A. M., Elshikh, M. S., Munir, A., Al‐Ghamdi, A. A., Alajmi, A. H., Alsubaie, Q. D., & Mustafa, A. E. M. A. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.06.041 · Cited by 24

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling

Yan, J., Xie, Y., Si, J., Gan, L., Li, H., Sun, C., Di, C., Zhang, J., Huang, G., Zhang, X., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020817 · Cited by 24

The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancer

Khoshghamat, N., Jafari, N., Tolou, V., Azami, S., Mirnourbakhsh, S. H., Khazaei, M., Ferns, G. A., Rajabian, M., & Avan, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119118 · Cited by 24

Combination Treatment With Inhibitors of ERK and Autophagy Enhances Antitumor Activity of Betulinic Acid in Non–small-Cell Lung Cancer In Vivo and In Vitro

Sun, C., Cao, D., Ren, Q., Zhang, S., Zhou, N., Mai, S., Feng, B. C., & Wang, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.684243 · Cited by 24

Ghrelin and Cancer: Examining the Roles of the Ghrelin Axis in Tumor Growth and Progression

Kotta, A. S., Kelling, A. S., Corleto, K. A., Sun, Y., & Giles, E. D. (2022) · Biomolecules · doi:10.3390/biom12040483 · Cited by 25

Structural insights into Ras regulation by SIN1

Zheng, Y., Ding, L., Meng, X., Potter, M., Kearney, A. L., Zhang, J., Sun, J., James, D. E., Yang, G., & Zhou, C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119990119 · Cited by 25

The SCF / KIT axis in human mast cells: Capicua acts as potent KIT repressor and ERK predominates PI3K

Franke, K., Kirchner, M., Mertins, P., Zuberbier, T., & Babina, M. (2022) · Allergy · doi:10.1111/all.15396 · Cited by 24

Clinical-pathological correlation of K-Ras mutation and ERK phosphorylation in colorectal cancer.

Tai, C.-J., Chang, C.-C., Jiang, M.-C., Yeh, C., Su, T., Wu, P.-R., Chen, C., Yeh, K.-T., Lin, S.-H., & Chen, H.-C. (2012) · PubMed · Cited by 24

Estrogen receptor ESR1 mediates activation of ERK1/2, CREB, and ELK1 in the corpus of the epididymis

Cavalcanti, F. N., Lucas, T. F. G., Lazari, M. F. M., & Porto, C. S. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0086 · Cited by 24

Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling

Azad, A., Lawen, A., & Keith, J. M. (2015) · BMC Systems Biology · doi:10.1186/s12918-014-0135-x · Cited by 24

Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle

Dogan, T., Gnad, F., Chan, J., Phu, L., Young, A. E., Chen, J., Doll, S., Stokes, M. P., Belvin, M. P., Friedman, L. S., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.792754 · Cited by 25

Shikimic Acid Promotes Oligodendrocyte Precursor Cell Differentiation and Accelerates Remyelination in Mice

Lu, F., Yin, D., Pu, Y., Liu, W., Li, Z., Shao, Q., He, C., & Cao, L. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-018-0322-7 · Cited by 25

TCF21 inhibits tumor-associated angiogenesis and suppresses the growth of cholangiocarcinoma by targeting PI3K/Akt and ERK signaling

Duan, H., Li, B., Zhuang, X. H., Wang, L., Cao, Q., Tan, L.-H., Qu, G.-F., & Xiao, S. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00264.2018 · Cited by 24

mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV

Yang, J. Y., Madrakhimov, S. B., Ahn, D. H., Chang, H. S., Jung, S. J., Nah, S. K., Park, H. Y., & Park, T. K. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0380-0 · Cited by 24

Synergistic Effects of Interferon-γ and Vitamin D3 Signaling in Induction of ILT-3highPDL-1high Tolerogenic Dendritic Cells

Švajger, U., & Rožman, P. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02627 · Cited by 24

The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1

Cervi, F., Saletti, V., Turner, K., Peron, A., Bulgheroni, S., Taddei, M., Briola, F. L., Canevini, M. P., & Vignoli, A. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01488-4 · Cited by 24

Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance

Rausch, M., Weiss, A., Zoetemelk, M., Piersma, S. R., Jiménez, C. R., B, J. R. V. B., & Nowak-Sliwinska, P. M. (2020) · Cancers · doi:10.3390/cancers12113172 · Cited by 24

The Targeted Therapies for Osteosarcoma via Six Major Pathways

Wang, S., Ren, Q., Li, G., Zhao, X., Zhao, X., & Zhang, Z. (2023) · Current Molecular Pharmacology · doi:10.2174/1874467217666230821142839 · Cited by 24

Therapeutic targeting of p90 ribosomal S6 kinase

Wright, E. B., & Lannigan, D. A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1297292 · Cited by 26

Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer

Hashemi, M., Khosroshahi, E. M., Asadi, S., Tanha, M., Mohseni, F. G., Sagha, R. A., Taheri, E., Vazayefi, P., Shekarriz, H., Habibi, F., et al. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.08.002 · Cited by 24

Inactivation of Nuclear Factor-Y Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation

Silvestre-Roig, C., Fernández, P., Esteban, V., Pello, Ó. M., Indolfi, C., Rodrı́guez, C., Rodríguez‐Calvo, R., López-Maderuelo, D., Bauriedel, G., Hutter, R., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300580 · Cited by 23

REV-ERBα alters circadian rhythms by modulating mTOR signaling

Dadon‐Freiberg, M., Chapnik, N., & Froy, O. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111108 · Cited by 23

Signal Transduction Regulators in Axonal Regeneration

Hausott, B., Glueckert, R., Schrott‐Fischer, A., & Klimaschewski, L. P. (2022) · Cells · doi:10.3390/cells11091537 · Cited by 24

PI 3K‐dependent multiple myeloma cell survival is mediated by the PIK 3 CA isoform

Hofmann, C., Stühmer, T., Schmiedl, N., Wetzker, R., Mottok, A., Rosenwald, A., Langer, C., Zovko, J., Chatterjee, M., Einsele, H., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12920 · Cited by 23

c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5

Kim, S.-H., Kim, J.-H., & Song, J. J. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2012.88 · Cited by 23

Enhancing value of clinical pharmacodynamics in oncology drug development: An alliance between quantitative pharmacology and translational science

Venkatakrishnan, K., & Ecsedy, J. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.544 · Cited by 23

And Akt‐ion! IQGAP1 in control of signaling pathways

Choi, S., & Anderson, R. A. (2017) · The EMBO Journal · doi:10.15252/embj.201796827 · Cited by 23

Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma Tumors

Sen, S., Meric‐Bernstam, F., Hong, D. S., Hess, K. R., & Subbiah, V. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx094 · Cited by 23

mTOR complexes differentially orchestrates eosinophil development in allergy

Zhu, C., Xia, L., Li, F., Zhou, L., Weng, Q., Li, Z., Wu, Y., Mao, Y., Zhang, C., Wu, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25358-z · Cited by 23

Towards understanding leydigioma: do G protein-coupled estrogen receptor and peroxisome proliferator–activated receptor regulate lipid metabolism and steroidogenesis in Leydig cell tumors?

Kotula‐Balak, M., Górowska-Wójtowicz, E., Milon, A., Pawlicki, P., Tworzydlo, W., Płachno, B. J., Krakowska, I., Hejmej, A., Wolski, J. K., & Bilińska, B. (2020) · PROTOPLASMA · doi:10.1007/s00709-020-01488-y · Cited by 23

Curcumin represses mTORC1 signaling in Caco-2 cells by a two-sided mechanism involving the loss of IRS-1 and activation of AMPK

Kaur, H., & Moreau, R. F. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109842 · Cited by 24

Impact of polystyrene microplastics (PS-MPs) on the entire female mouse reproductive cycle: Assessing reproductive toxicity of microplastics through in vitro follicle culture

Jeong, J., Mai, N. T. Q., Moon, B.-S., & Choi, J. K. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118228 · Cited by 23

Na+/K+-ATPase α1 isoform mediates ouabain-induced expression of cyclin D1 and proliferation of rat Sertoli cells

Lucas, T. F. G., Amaral, L. S., Porto, C. S., & Quintas, L. E. M. (2012) · Reproduction · doi:10.1530/rep-12-0232 · Cited by 23

Genetic targeting of B-RafV600E affects survival and proliferation and identifies selective agents against BRAF-mutant colorectal cancer cells

Hirschi, B., Gallmeier, E., Ziesch, A., Marschall, M. K., & Kolligs, F. T. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-122 · Cited by 22

Quantification of growth factor signaling and pathway cross talk by live-cell imaging

Gross, S. M., & Rotwein, P. S. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00312.2016 · Cited by 21

CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia

Chiang, Y.-J., Liao, W.-T., Ho, K.-C., Wang, S., Chen, Y., Ho, C., Huang, S.-F. K., Shih, L., Yang‐Yen, H., & Yen, J. J.-Y. (2018) · Oncogene · doi:10.1038/s41388-018-0507-6 · Cited by 22

Roles of microRNAs in Regulating Cancer Stemness in Head and Neck Cancers

Fitriana, M., Hwang, W., Chan, P.-Y., Hsueh, T.-Y., & Liao, T. (2021) · Cancers · doi:10.3390/cancers13071742 · Cited by 24

Kaposiform hemangioendothelioma further broadens the phenotype of PIK3CA ‐related overgrowth spectrum

Carli, D., Kalantari, S., Manicone, R., Coppo, P., di Celle, P. F., Selva, R. L., Santoro, F., Ranieri, C., Cardaropoli, S., Fagioli, F., et al. (2021) · Clinical Genetics · doi:10.1111/cge.14047 · Cited by 22

Therapeutic implication of Sonic Hedgehog as a potential modulator in ischemic injury

Mohan, M., Mannan, A., & Singh, T. G. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00505-0 · Cited by 22

Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies

Tripathy, R. K., & Pande, A. H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122593 · Cited by 23

Inhibition of Galectin-1 Sensitizes HRAS-driven Tumor Growth to Rapamycin Treatment

Michael, J. V., Wurtzel, J. G. T., & Goldfinger, L. E. (2016) · Anticancer Research · doi:10.21873/anticanres.11074 · Cited by 22

Modulation of oncogenic signaling networks by Kaposi’s sarcoma-associated herpesvirus

Wong, J. P., & Damania, B. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0101 · Cited by 22

The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity

Rubens, J. A., Wang, S. Z., Price, A. C., Weingart, M., Allen, S. J., Orr, B. A., Eberhart, C. G., & Raabe, E. H. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox067 · Cited by 23

Developmental song learning as a model to understand neural mechanisms that limit and promote the ability to learn

London, S. E. (2017) · Behavioural Processes · doi:10.1016/j.beproc.2017.11.008 · Cited by 23

Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro

Citi, V., Re, M. D., Martelli, A., Calderone, V., Breschi, M. C., & Danesi, R. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3543-6 · Cited by 22

Upregulation of EphB3 in gastric cancer with acquired resistance to a FGFR inhibitor

Lee, S., Na, Y. J., Jeong, Y. A., Kim, J. L., Oh, S. C., & Lee, D.-H. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.07.008 · Cited by 23

Dermatological manifestations in cardiofaciocutaneous syndrome: a prospective multicentric study of 45 mutation‐positive patients

Bessis, D., Morice‐Picard, F., Bourrat, E., Abadie, C., Aouinti, S., Baumann, C., Best, M., Bursztejn, A. ‐., Capri, Y., Chiavérini, C., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.17077 · Cited by 22

Dual inhibitors of RAF-MEK-ERK and PI3K-PDK1-AKT pathways: Design, synthesis and preliminary anticancer activity studies of 3-substituted-5-(phenylamino) indolone derivatives

Yu, Z., Chen, Z., Su, Q., Ye, S., Yuan, H., Kuai, M., Lv, M., Tu, Z., Yang, X., Liu, R., et al. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.01.028 · Cited by 22

Small Molecule SOS1 Agonists Modulate MAPK and PI3K Signaling via Independent Cellular Responses

Akan, D. T., Howes, J. E., Sai, J., Arnold, A. L., Beesetty, Y., Phan, J., Olejniczak, E. T., Waterson, A. G., & Fesik, S. W. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b00869 · Cited by 22

Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2+/calcineurin/Erk pathway

Liu, Z., Jiang, L., Li, Y., Xie, B., Xie, J., Wang, Z., Zhou, X., Jiang, H., Fang, Y., Pan, H., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.019 · Cited by 22

Defining subpopulations of differential drug response to reveal novel target populations

Keshava, N., Toh, T. S., Yuan, H., Yang, B., Menden, M. P., & Wang, D. Y. Q. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0113-4 · Cited by 22

Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo

Schulte, A., Ewald, F., Spyra, M., Smit, D. J., Jiang, W., Salamon, J., Jücker, M., & Mautner, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041548 · Cited by 22

Dynamic cross‐talk between PI3‐kinase/Akt and Ras/ERK pathways in EGF receptor signaling that can affect drug sensitivity in tumor cells

Aksamitiene, E., Kiyatkin, A. B., & Hoek, J. B. (2010) · The FASEB Journal · doi:10.1096/fasebj.24.1_supplement.715.2 · Cited by 1

Integration of AKT and ERK Signaling Pathways in Cancer: Biological and Therapeutic

She, Q. (2013)

Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance

Aksamitiene, E., Kiyatkin, A., & Kholodenko, B. N. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110609 · Cited by 479

Cotargeting survival signaling pathways in cancer

Grant, S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36898 · Cited by 170

PI3K‐dependent cross‐talk interactions converge with Ras as quantifiable inputs integrated by Erk

Wang, C., Cirit, M., & Haugh, J. M. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.4 · Cited by 87